Sandra Tomek

Contribution of Epigenetic Silencing of Tumor Necrosis Factor–Related Apoptosis Inducing Ligand Receptor 1 (DR4) to TRAIL Resistance and Ovarian Cancer

Peter Horak, Dietmar Pils, Griet Haller et al. · Molecular Cancer Research · 2005 · 148 citations · Full text

Monitoring of Serum Her-2/<b> <i>neu</i> </b> Predicts Response and Progression-Free Survival to Trastuzumab-Based Treatment in Patients with Metastatic Breast Cancer

Wolfgang J. Köstler, Barbara Schwab, Christian F. Singer et al. · Clinical Cancer Research · 2004 · 144 citations · Full text

¹¹C-Acetate Positron Emission Tomography Imaging and Image Fusion With Computed Tomography and Magnetic Resonance Imaging in Patients With Recurrent Prostate Cancer

Stefan De Wachter, Sandra Tomek, Amir Kurtaran et al. · Journal of Clinical Oncology · 2006 · 109 citations · Full text

Resistance to TRAIL-induced apoptosis in ovarian cancer cell lines is overcome by co-treatment with cytotoxic drugs

Sandra Tomek, Peter Horak, Ingrid Pribill et al. · Gynecologic Oncology · 2004 · 54 citations

Medicine, Apoptosis, Pharmacology +9

Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancer

Thomas Brodowicz, Roswitha Wolfram, Wolfgang J. Köstler et al. · Anti-Cancer Drugs · 2000 · 37 citations